Cat.No.: | BSM-0157 |
Product Name: | JNJ-26481585 |
CAS No.: | 875320-29-9 |
Figure: | |
Synonyms: | N-hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)methyl)piperidin-1-yl)pyrimidine-5-carboxamide; Quisinostat |
Description: | JNJ-26481585 is a second-generation pyrimidyl-hydroxamic acid histone deacetylase (HDAC) inhibitor with high cellular potency towards Class I and II HDACs. JNJ-26481585 induces histone acetylationand inhibits cancer cell proliferation. |
Appearance: | Crystalline solid |
Molecular Weight: | 394.21 |
Purity: | ≥98% by HPLC |
Storage: | -20°C |
Targets: | HDAC |
Molecular Formula: | C21H26N6O2 |
MDL Number: | MFCD17019334 |
Solubility: | DMSO (>50 mg/ml) |
Shipping Conditions: | Gel Pack |
Warning: | For Research Use Only! Not For Use in Humans. |
Product Types | ||
◆ Extracts & Lysates | ||
EL-0006 | Recombinant Human HDAC1 293 Cell Lysate | Inquiry |
EL-0007 | Recombinant Human HDAC2 293 Cell Lysate | Inquiry |
EL-0008 | Recombinant Human HDAC3 Cell Lysate | Inquiry |
EL-0009 | Recombinant Human HDAC4 Cell Lysate | Inquiry |
◆ Bioactive Small Molecules | ||
BSM-0007 | Tubacin | Inquiry |
Related Gene / Proteins | |||
HDAC | HDAC1 | HDAC10 | HDAC11 |
HDAC2 | HDAC3 | hdac4 | hdac5 |
HDAC6 | hdac7 | HDAC8 | hdac9 |
USA
Enter your email here to subscribe.
Follow us on
Easy access to products and services you need from our library via powerful searching tools